MeSH D016778 - falciparum malaria
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Chloroquine | Chloroquine | 1982-01-13 | |||
| Pyrimethamine | Pyrimethamine | 2021-08-13 | ||||
| Quinine | Quinine | 2012-09-28 | ||||
| Novast Laboratories | Primaquine | Primaquine | 2016-06-23 | |||
| Quinine | Quinine | 2015-07-22 | ||||
| GSK | Atovaquone, Proguanil | Malarone | 2000-07-14 | |||
| Roche | Pyrimethamine, Sulfadoxine | Fansidar | 1982-01-01 | |||
| Mefloquine | Lariam | 1989-05-02 | ||||
| Lupin Research | Quinine | Quinine | 2015-04-24 | |||
| Sandoz | Mefloquine | Mefloquine | 2002-02-20 | |||
| Novartis | Lumefantrine, Artemether | Coartem | 2009-04-07 | |||
| Sanofi | Chloroquine | Aralen | 1982-01-01 | |||
| Chloroquine, Primaquine | Aralen W/ Primaquine | 1982-01-01 | ||||
| Primaquine | Primaquine | 1982-01-01 | ||||
| Aurobindo Pharma | Pyrimethamine | Pyrimethamine | 2022-10-25 | |||
| Quinine | Quinine | 2012-12-14 | ||||
| Barr Pharmaceuticals | Mefloquine | Mefloquine | 2003-12-29 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
83%24/29
Phase 2
73%22/30
Phase 3
92%33/36
Approved: 9Overall Success rate: 56%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use